These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1081 related articles for article (PubMed ID: 31534499)
1. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma. Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499 [TBL] [Abstract][Full Text] [Related]
2. AP-2α decreases TMZ resistance of recurrent GBM by downregulating MGMT expression and improving DNA damage. Huang G; Ouyang M; Xiao K; Zhou H; Zhong Z; Long S; Li Z; Zhang Y; Li L; Xiang S; Ding X Life Sci; 2024 Nov; 357():123111. PubMed ID: 39369843 [TBL] [Abstract][Full Text] [Related]
3. Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma. Ding C; Yi X; Chen X; Wu Z; You H; Chen X; Zhang G; Sun Y; Bu X; Wu X; Lin Z; Gu J; Lin Y; Kang D J Exp Clin Cancer Res; 2021 May; 40(1):164. PubMed ID: 33975615 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-29b promotes cell sensitivity to Temozolomide by targeting STAT3 in glioma. Xu JX; Yang Y; Zhang X; Luan XP Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1922-1931. PubMed ID: 32141561 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway. Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282 [TBL] [Abstract][Full Text] [Related]
6. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2. Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476 [TBL] [Abstract][Full Text] [Related]
7. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C; Feng S; Chen L Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913 [TBL] [Abstract][Full Text] [Related]
8. Circ-VPS18 Knockdown Enhances TMZ Sensitivity and Inhibits Glioma Progression by MiR-370/RUNX1 Axis. Li W; Ma Q; Liu Q; Yan P; Wang X; Jia X J Mol Neurosci; 2021 Jun; 71(6):1234-1244. PubMed ID: 33188501 [TBL] [Abstract][Full Text] [Related]
9. NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/ Chen M; Cheng Y; Yuan Z; Wang F; Yang L; Zhao H Cancer Biother Radiopharm; 2020 Mar; 35(2):101-108. PubMed ID: 31750728 [No Abstract] [Full Text] [Related]
10. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms for hypoxia Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis. Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242 [TBL] [Abstract][Full Text] [Related]
13. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway. Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578 [TBL] [Abstract][Full Text] [Related]
14. Exosomal circ-HIPK3 Facilitates Tumor Progression and Temozolomide Resistance by Regulating miR-421/ Han C; Wang S; Wang H; Zhang J Cancer Biother Radiopharm; 2021 Sep; 36(7):537-548. PubMed ID: 32644821 [No Abstract] [Full Text] [Related]
15. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis. Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT. Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036 [TBL] [Abstract][Full Text] [Related]
18. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression. Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225 [TBL] [Abstract][Full Text] [Related]
19. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285 [TBL] [Abstract][Full Text] [Related]